Journal of Clinical Medicine (Jul 2022)

Screening Tool to Identify Patients with Advanced Aortic Valve Stenosis

  • Sameh Yousef,
  • Andrea Amabile,
  • Chirag Ram,
  • Huang Huang,
  • Varun Korutla,
  • Saket Singh,
  • Ritu Agarwal,
  • Roland Assi,
  • Rita K. Milewski,
  • Yawei Zhang,
  • Prakash A. Patel,
  • Markus Krane,
  • Arnar Geirsson,
  • Prashanth Vallabhajosyula

DOI
https://doi.org/10.3390/jcm11154386
Journal volume & issue
Vol. 11, no. 15
p. 4386

Abstract

Read online

(1) Background: The clinical burden of aortic stenosis (AS) remains high in Western countries. Yet, there are no screening algorithms for this condition. We developed a risk prediction model to guide targeted screening for patients with AS. (2) Methods: We performed a cross-sectional analysis of all echocardiographic studies performed between 2013 and 2018 at a tertiary academic care center. We included reports of unique patients aged from 40 to 95 years. A logistic regression model was fitted for the risk of moderate and severe AS, with readily available demographics and comorbidity variables. Model performance was assessed by the C-index, and its calibration was judged by a calibration plot. (3) Results: Among the 38,788 reports yielded by inclusion criteria, there were 4200 (10.8%) patients with ≥moderate AS. The multivariable model demonstrated multiple variables to be associated with AS, including age, male gender, Caucasian race, Body Mass Index ≥ 30, and cardiovascular comorbidities and medications. C-statistics of the model was 0.77 and was well calibrated according to the calibration plot. An integer point system was developed to calculate the predicted risk of ≥moderate AS, which ranged from 0.0002 to 0.7711. The lower 20% of risk was approximately 0.15 (corresponds to a score of 252), while the upper 20% of risk was about 0.60 (corresponds to a score of 332 points). (4) Conclusions: We developed a risk prediction model to predict patients’ risk of having ≥moderate AS based on demographic and clinical variables from a large population cohort. This tool may guide targeted screening for patients with advanced AS in the general population.

Keywords